Chongqing Zhifei Biological Products Co., Ltd.
300122
Clasificación en acciones
#3688
Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily... Chongqing Zhifei Biological Products Co., Ltd. is a Chinese firm primarily engaged in the innovation, manufacturing, and commercialization of vaccines and other biological pharmaceuticals within the country. The company's establishment dates back to 2009, and its main operational base is located in Chongqing, China.
Precio por acción
$1.91
Capitalización bursátil
$4.57B
Cambio (1 día)
5.32%
Cambio (1 año)
-32.90%
País
CN
Comercio Chongqing Zhifei Biological Products Co., Ltd. (300122)
Categoría
Healthcare
Ganancias de Chongqing Zhifei Biological Products Co., Ltd. (300122)
Ganancias en Jun 2026 TTM: $-2.56B
Secondo gli ultimi rapporti finanziari di Chongqing Zhifei Biological Products Co., Ltd., gli utili attuali della società sono $-2.56B. Nel 2023, la società ha registrato un utile di $1.32B, un aumento con respecto a agli utili del 2022, che erano di $1.26B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Chongqing Zhifei Biological Products Co., Ltd. desde 2007 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $-2.56B | -930.41% |
| 2024 | $308.76M | -76.61% |
| 2023 | $1.32B | 4.43% |
| 2022 | $1.26B | -32.67% |
| 2021 | $1.88B | 218.18% |
| 2020 | $589.97M | 48.56% |
| 2019 | $397.14M | 61.43% |
| 2018 | $246.01M | 217.15% |
| 2017 | $77.57M | 1,407.01% |
| 2016 | $5.15M | -85.51% |
| 2015 | $35.52M | 25.56% |
| 2014 | $28.29M | 12.36% |
| 2013 | $25.18M | -37.88% |
| 2012 | $40.54M | 11.01% |
| 2011 | $36.52M | -20.43% |
| 2010 | $45.89M | 20.19% |
| 2009 | $38.18M | 17.29% |
| 2008 | $32.55M | 28.15% |
| 2007 | $25.40M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $5.27B | -305.73% |
US
|
|
| $-3.09B | 20.40% |
US
|
|
| $-4.02B | 56.64% |
AU
|
|
| $1.95B | -176.08% |
NL
|
|
| - | - |
CH
|
